
Matthew James Ehrhardt MD
Assistant Member, St. Jude Children's Research Hospital
Join to View Full Profile
262 Danny Thomas PlMemphis, TN 38105
Phone+1 888-226-4343
Dr. Ehrhardt is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- I am a pediatric hematologist/oncologist in Memphis, TN affiliated with St. Jude Children's Research Hospital. I received my medical degree from University of Illinois College of Medicine and am experienced in pediatric Hodgkin lymphoma, pediatric non-Hodgkin lymphoma, and health outcomes research. My research focuses on long-term health outcomes in childhood cancer survivors and optimizing delivery of care to these individuals.
Education & Training
- Medical College of Wisconsin Affiliated HospitalsFellowship, Pediatric Hematology/Oncology, 2011 - 2014
- Medical College of Wisconsin Affiliated HospitalsResidency, Internal Medicine/Pediatrics, 2007 - 2011
- University of Illinois College of MedicineClass of 2007
Certifications & Licensure
- TN State Medical License 2014 - 2025
- WI State Medical License 2008 - 2017
- American Board of Internal Medicine Internal Medicine
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Publications & Presentations
PubMed
- 1 citationsTrends in physical functioning in acute lymphoblastic leukemia and non-Hodgkin lymphoma survivors across three decades.Carmen L Wilson, Kari L Bjornard, Robyn E Partin, Nina S Kadan-Lottick, Paul C Nathan
Journal of Cancer Survivorship. 2025-04-01 - Metabolic syndrome in childhood, adolescent, and young adult cancer survivors: recommendations for surveillance from the International Late Effects of Childhood Cancer...Selina R van den Oever, Renée L Mulder, Kevin C Oeffinger, Jourik A Gietema, Roderick Skinner
European Journal of Endocrinology. 2025-03-27 - Pediatric relapsed/refractory ALK-positive anaplastic large cell lymphoma treatment and outcomes in the targeted-drug era.Lianna J Marks, Victor Ritter, Jennifer E Agrusa, Kala Y Kamdar, Julie Rivers
Blood Advances. 2025-03-25
Journal Articles
- Polygenic Determinants for Subsequent Breast Cancer Risk in Survivors of Childhood Cancer: The St Jude Lifetime Cohort Study (SJLIFE)Kim E Nichols, Melissa M Hudson, Chimene A Kesserwan, Matthew J Ehrhardt, James R Downing, Clinical Cancer Research
Press Mentions
- St. Jude Scientists Explore Role of Socioeconomic Deprivation in Cancer Survivors' Mortality RiskFebruary 14th, 2023
- Access Matters: Lack of Resources Is Associated with Increased Mortality in Childhood Cancer SurvivorsFebruary 10th, 2023
- Screenings for Cardiac Dysfunction Among Childhood Cancer Survivors Can Be More Precisely TailoredAugust 15th, 2020
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: